Item 7.01 Regulation FD Disclosure.

On December 24, 2021, Jupiter Wellness, Inc. (the "Company") issued a letter to its stockholders providing an overview of Next Frontier Pharmaceuticals, Inc., a corporation with which the Company will merge. A copy of the letter to stockholders is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

Copies of the shareholder letter are attached as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Item 7.01 of this Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing of ours under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference to this Form 8-K in such filing.





Cautionary Statements

This filing and attached exhibits includes "forward-looking statements." All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Actual results could vary significantly from those expressed or implied in such statements and are subject to a number of risks and uncertainties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. The forward-looking statements involve risks and uncertainties that affect our operations and financial performance. We do not undertake any duty to update any forward-looking statement except as required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits


    99.1       Letter to Stockholders
             Cover Page Interactive Data File (embedded within the Inline XBRL
    104      document)




2

© Edgar Online, source Glimpses